Literature DB >> 12375269

Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder.

Catherine Booth1, Patricia Harnden, Peter J Selby, Jennifer Southgate.   

Abstract

Tenascin-C (TN-C) is an extracellular matrix glycoprotein expressed along epithelial/stromal boundaries during tissue remodelling events, such as those that occur during morphogenesis, wound healing, and tumour invasion. Using clinical specimens and a range of in vitro models that simulate homeostasis, wound healing, and malignant progression, this study sought to establish the patterns of TN-C expression in normal and neoplastic bladder and to determine the role of exogenous transforming growth factor beta-1 (TGFbeta-1), interleukin-4 (IL-4), basic fibroblast growth factor (bFGF), tumour necrosis factor alpha (TNFalpha), and interferon gamma (IFNgamma) in the induction of TN-C expression by bladder uro-epithelial cells. The findings indicate that normal urothelial cells may express TN-C, with both TGFbeta-1 and IL-4 able to induce expression. TN-C was not expressed in neoplastic urothelium, although both TN-C and TGFbeta-1 may be involved in tissue remodelling during papillary tumour formation and invasion. Furthermore, the urothelium of high-grade papillary tumours and carcinoma in situ specimens exhibited little TGFbeta-1 immunoreactivity, compared with the urothelium of low-grade tumours and normal specimens, suggesting an association between TGFbeta-1 expression and urothelial differentiation. A tumour invasion model, in which established bladder cancer cell lines were seeded onto a normal bladder stroma, corroborated the evidence from the clinical specimens and demonstrated that TN-C was strongly expressed around foci of stromal invasion. Thus, TN-C immunoreactivity may provide an additional tool in the assessment of early stromal invasion in bladder cancer. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12375269     DOI: 10.1002/path.1214

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  13 in total

1.  Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder.

Authors:  Alexander Berndt; Katharina Anger; Petra Richter; Laura Borsi; Simon Brack; Michela Silacci; Marcus Franz; Heiko Wunderlich; Mieczyslaw Gajda; Luciano Zardi; Dario Neri; Hartwig Kosmehl
Journal:  J Cancer Res Clin Oncol       Date:  2006-05-31       Impact factor: 4.553

2.  Role of serum and urine transforming growth factor beta 1, matrix metallopeptidase 9, tissue inhibitor of metalloproteinase 2, and nerve growth factor beta levels and serum neutrophil-to-lymphocyte ratio in predicting recurrence and progression risks in patients with primary non-muscle invasive bladder cancer.

Authors:  Özgür Efiloğlu; Banu İşbilen Başok; Turgay Turan; Tuncay Toprak; Bülent Erol; Turhan Çaşkurlu; Asıf Yıldırım
Journal:  Turk J Urol       Date:  2020-02-07

3.  Tenascin-C in chronic sclerosing sialadenitis.

Authors:  Apostolos Epivatianos; Fotis Iordanidis; Dimitrios Andreadis; Savas Iordanidis; Athanasios Poulopoulos; Anastasios Markopoulos
Journal:  Head Neck Pathol       Date:  2011-05-11

Review 4.  Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.

Authors:  Alexander Berndt; Petra Richter; Hartwig Kosmehl; Marcus Franz
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

5.  Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer.

Authors:  A Brunner; C Mayerl; A Tzankov; I Verdorfer; I Tschörner; H Rogatsch; G Mikuz
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

6.  The role of structural extracellular matrix proteins in urothelial bladder cancer (review).

Authors:  Andrea Brunner; Alexandar Tzankov
Journal:  Biomark Insights       Date:  2007-11-05

7.  Identification of a tumor microenvironment-associated prognostic gene signature in bladder cancer by integrated bioinformatic analysis.

Authors:  Zhengchun Liu; Xiuli Liu; Rui Cai; Meilian Liu; Rensheng Wang
Journal:  Int J Clin Exp Pathol       Date:  2021-05-15

8.  Expression of TGFβ-1 and EHD1 correlated with survival of non-small cell lung cancer.

Authors:  Yuanyuan Gao; Yan Wang; Lichun Sun; Qingwei Meng; Li Cai; Xiaoqun Dong
Journal:  Tumour Biol       Date:  2014-06-20

9.  Expression of molecular factors correlated with metastasis in small cell lung cancer and their significance.

Authors:  Xiao-Xia Li; Rui-Jian Li; Lu-Jun Zhao; Ning-Bo Liu; Ping Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  Differentiation-associated reprogramming of the transforming growth factor β receptor pathway establishes the circuitry for epithelial autocrine/paracrine repair.

Authors:  Jonathan M Fleming; Saqib Shabir; Claire L Varley; Lisa A Kirkwood; Angela White; Julie Holder; Ludwik K Trejdosiewicz; Jennifer Southgate
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.